Olink Proteomics Horizons 2026

Connect with the proteomics community at Olink Proteomics Horizons 2026

Join researchers, scientists and proteomics leaders for a multi-city scientific exchange designed to spark discussion, share practical perspectives and explore how proteomics is advancing human disease research.

Choose the location and sessions most relevant to your work. Capacity is limited and registration is required.

San Francisco | September 10, 2026
EVENT CONCLUDED
AC Hotel San Francisco Airport/Oyster Point Waterfront

Boston | September 22-23, 2026

MAX CAPACITY REACHED
Hyatt Regency Boston Cambridge

Amsterdam | October 1-2, 2026

nhow Amsterdam RAI

About the event

Olink Proteomics Horizons brings together researchers from academia, pharma, clinical research and translational science to exchange ideas, learn from invited speakers and connect with peers working across biomarker discovery and proteomics-enabled research.

Each Summit includes scientific presentations, networking opportunities and a poster session. Boston and Amsterdam also include optional second-day programmes for audiences who want a deeper, more focused experience.

Complete the form to request your place and receive agenda updates, speaker announcements and practical event information.

The San Francisco Summit has reached max capacity at this time.

San Francisco Summit

Time	Program	Description
10:00	Arrival and welcome coffee	Check in, collect your badge and connect with other attendees before the program begins.
10:30-11:00	Markers of cellular senescence and aging in plasma and tissue	Birgit Schilling, PhD, Professor and Director of the Mass Spectrometry Core, Buck Institute for Research on Aging, Novato, CA, USA
11:00-11:30	Case studies where Olink facilitateded our biomarker research	Vivian Zhao, Principal Scientist, AbbVie, AbbVie Bay Area, South San Francisco, CA, USA
11:30-12:00	Long COVID (LC) - Revitalized: A percision medicine driven phase III double-blinded, placebo controlled, multi-arm platform clinical drug trial	Douglas D. Fraser, MD, PhD, FRCPC, Professor and Clinician Scientist, GSK Chair in Clinical Pharmacology, Departments of Pediatrics, Physiology & Pharmacology, and Clinical Neurological Sciences, Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada
12:00-1:00	Lunch and networking	Continue the conversation with peers, speakers and Olink scientists over lunch.
1:00-1:30	Proteomic insights into the prodromal phases of chronic neurological diseases	Ahmed Abdelhak, MD, Assistant Professor of Neurology, University of California, San Francisco, School of Medicine, San Francisco, CA, USA
1:30-2:00	Proteomic signatures as a compass for organ health	Tony Wyss-Coray, PhD, Professor of Neurology and Neurological Sciences, Stanford University School of Medicine, and Co-Director of the Knight Initiative for Brain Resilience, Stanford, CA, US
2:00-2:30	Invited scientific talk	Hear from KOLs sharing perspectives from pharma, academia, and translational research
2:30-3:00	Coffee break	Informal networking and time to connect with other attendees.
3:00-3:30	From data to insight	Per Eriksson, Manager Data Science Customer Applications, Olink, part of Thermo Fisher Scientific
3:30-4:00	The Proteomics Horizon - beyond discovery	Yan Zhang, President, Olink, part of Thermo Fisher Scientific
4:00-6:00	Poster session and networking	Continue the scientific exchange through posters, informal discussion and peer networking.
6:00	Floating dinner	The day concludes with an informal dinner for registered attendees.

Boston Summit

The Day 1 Summit program is designed as an in-person scientific exchange with a balance of invited talks, practical data perspectives, informal discussion and networking. Final session titles and timings may vary by location.

Time	Program element	Description
10:00	Arrival and welcome coffee	Check in, collect your badge and connect with other attendees before the program begins.
10:15-10:30	Opening remarks and keynote	Yan Zhang, President, Olink, part of Thermo Fisher Scientific
10:30-11:00	Insights from large-scale proteomics and implications	Benjamin B. Sun, PhD, Director, Head of Population Health Omics, Informatics and Predictive Sciences, Bristol Myers Squibb
11:00-11:30	Olink proteomics supports the microsampling ecosystem and reveals insights from site of disease sampling in atopic dermatitis	Matthew Blatnik, PhD, Associate Director, Immunology / Precision Medicine, AbbVie Bioresearch Center, AbbVie
11:30-12:00	Mapping the temporal blood proteome of preclinical Crohn's disease	Williams Turpin, PhD, Translational Research Scientist, Sinai Health, Toronto, Ontario, Canada
12:00-1:00	Lunch and networking	Continue the conversation with peers, speakers and Olink scientists over lunch.
1:00-1:30	Decoding Neurodegeneration Through Blood: Proteomic Signatures of ALS and Parkinson Disease	Sonja W. Scholz, MD, PhD, Senior Investigator and Chief, Neurodegenerative Diseases Research Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA
1:30-2:00	The Serum Proteome: A Window into CD19 CAR T-Cell Response and Toxicity in Large B-Cell Lymphoma	Luca Paruzzo, MD, Postdoctoral Fellow, Ruella Laboratory, Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania
2:00-2:30	Closing the Lead-Time Gap: A Window into CD19 CAR T-Cell Response and Toxicity in Large B-Cell Lymphoma	Andrew Nixon, PhD, MBA, Professor of Medicine, Duke University Medical Center
2:30-3:00	Coffee break
3:00-3:30	The Evolution of Biomarker Testing in Cardiovascular Disease	James Louis Januzzi, MD, Hutter Family Professor of Medicine at Harvard Medical School and cardiologist, Mass General Brigham
3:30-4:00	Depth Meets Precision: Integrating Discovery and Targeted Proteomics in Neurodegenerative Disease	Beatrix Ueberheide, PhD, Director Proteomics Laboratory, NYU Langone Health
4:00-4:20	Biobanks to Breakthroughs	Tony Qian, Head of Data Science, Olink, part of Thermo Fisher Scientific
4:20-4:30	Closing remarks	Evan Mills, Vice President, Business Development, Olink, part of Thermo Fisher Scientific
4:30-6:15	Poster session and networking	Continue the scientific exchange through posters, informal discussion and peer networking.
6:15-8:00	Dinner

Who should attend?

Designed for researchers, biostatisticians, bioinformaticians, platform teams, and scientific leaders who want to get more value from their Olink data.

About the event

From Olink data to deeper biological insight: a community day on downstream analysis, integration, and emerging tools

This interactive second day will focus on the steps that follow biomarker discovery: downstream analysis workflows, data interpretation, multi-omics integration, tool adoption, and emerging approaches such as AI-assisted analytics. Through customer stories, expert-led discussions, and community roundtables, participants will explore how different teams are building, scaling, and applying data analysis pipelines in real-world research settings.

The day is designed as a collaborative forum. Attendees will have the opportunity to hear from peers, exchange experiences, discuss common challenges, and share perspectives on what is needed to make advanced proteomics analysis more accessible, reproducible, and impactful.

Agenda at a glance

Time	Program	Description
9:00-9:30	Arrival and welcome coffee	Check in, collect your badge and connect with other attendees before the program begins.
9:30-9:45	Welcome address	Kirsten Tief-Kuery, VP Global Commercial, Olink, part of Thermo Fisher Scientific
9:45-10:15	Cross-platform proteomics reveals reproducible biomarkers and novel mechanisms beyond Amyloid and Tau in Alzheimer’s Disease	Pallavi Sachdev, Vice President & Head, Translational Science, DHBL, Eisai
10:15-10:45	Serenity AI for Olink Proteomics and individual health modeling	Jamie Heywood, Founder & CEO, Alden Scientific
10:45-11:15	From discovery to translation, end-to-end	Eva Loeb, Sr. Manager, Product Management, Olink, part of Thermo Fisher Scientific Kerhan Woo, Sr Manager, Product Management, Olink, part of Thermo Fisher Scientific
11:15-11:45	Leveraging external cohorts for discovery of disease mechanisms with Olink Explore HT	Wenyu Zhou, Director, R&D, Teal Rise
11:45-12:15	Discussion	Group discussion to address questions, share experiences, and connect study design and data integration concepts to real-world research challenges.
12:15-1:15	Lunch
1:15-1:45	Decoding endothelial contributions to Alzheimer Disease using large-scale proteomics	Rawan Tarawneh, MD, Associate Professor of Neurology and Director of Cognitive Neurology, Saint Louis University
1:45-2:30	Integrative proteomics in practice: Harmonizing Mass Spec and PEA data for in depth biological insight	Kristin Hellman, Global Product Manager, Olink, part of Thermo Fisher Scientific Tony Qian, Head of Global Data Science Customer Applications, Olink, part of Thermo Fisher Scientific Kristyn Chin, Data Scientist III, Olink, part of Thermo Fisher Scientific Amrita Kar, Staff Field Bioinformatics Scientist, Olink, part of Thermo Fisher Scientific
2:30-2:45	The art of study design	Neil Skinner, Field Application Scientist, Olink, part of Thermo Fisher Scientific
2:45-3:45	Roundtable discussion	Interactive roundtable on data analysis needs, available tools, best practices, and opportunities to strengthen the Olink data ecosystem.
3:45-4:00	Closing remarks	End of meeting

Amsterdam Summit

Time	Program element	Description
10:00	Arrival and welcome coffee	Check in, collect your badge and connect with other attendees before the programme begins.
10:30-11:00	Opening remarks and keynote	Stephen Charnock-Jones, PhD, Professor of Reproductive Biology, Department of Obstetrics and Gynaecology, University of Cambridge, Cambridge, UK
11:00-11:30	Invited scientific talks	Petter Brodin, MD, PhD, Professor of Pediatric Immunology, Karolinska Institutet, and Garfield Weston Chair in Pediatric Immunology, Imperial College London, London, UK and Stockholm, Sweden
11:30-12:00	Invited scientific talks	Jonas Halfvarson, MD, PhD, Professor of Gastroenterology and Consultant Gastroenterologist, School of Medical Sciences, Örebro University, Campus USÖ, Örebro, Swede
12:00-13:00	Lunch and networking	Continue the conversation with peers, speakers and Olink scientists over lunch.
13:00-13:30	Invited scientific talks	Mathias Uhlén, PhD, Senior Professor of Microbiology, Department of Protein Science, KTH Royal Institute of Technology, and Founding Director, Science for Life Laboratory (SciLifeLab), Stockholm, Sweden
13:30-14:00	Invited scientific talks	Tej Pandya, MBBS, Institute of Health Informatics, University College London, and Visiting Scientist, Francis Crick Institute, London, UK
14:00-14:30	Invited scientific talks	Faiez Zannad, MD, PhD, Professor Emeritus of Therapeutics and Cardiology, Université de Lorraine, and Director of the Clinical Investigation Center (CIC) Inserm, Nancy, France
14:30-15:00	Coffee break	Informal networking and time to connect with other attendees.
15:00-15:30	From data to Insight	A practical session focused on how proteomics data can move from measurement to biological insight.
15:30-16:00	Wrap-up discussion and panel	A closing discussion on what is next for proteomics-enabled research.
16:00-18:00	Poster session and networking	Continue the scientific exchange through posters, informal discussion and peer networking.
18:00	Floating dinner	The day concludes with an informal dinner for registered attendees.

Who should attend?

This day is intended for Core Facility and Olink Certified Service Providers' attendees only. Please select this option during registration if your role is connected to a core facility or shared research service environment.

About the event

The Amsterdam Core Facilities Day is an exclusive day programme for core facility leaders and teams supporting proteomics research. The programme is designed to be practical and discussion-led, with sessions on study design, workflow efficiency, quality management, data interpretation and best-practice exchange across the core facility community.